Cargando…

Multiplexed VaxArray immunoassay for rapid antigen quantification in measles and rubella vaccine manufacturing

Measles-containing vaccines (MCV), specifically vaccines against measles and rubella (MR), are extremely effective and critical for the eradication of measles and rubella diseases. In developed countries, vaccination rates are high and vaccines are readily available, but continued high prevalence of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gillis, Jacob H., Thomas, Keely N., Manoharan, Senthilkumar, Panchakshari, Mallikarjuna, Taylor, Amber W., Miller, David F., Byrne-Nash, Rose T., Riley, Christine, Rowlen, Kathy L., Dawson, Erica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Regular paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484809/ https://www.ncbi.nlm.nih.gov/pubmed/34622199 http://dx.doi.org/10.1016/j.jvacx.2021.100113

Ejemplares similares

VaxArray immunoassay for the multiplexed quantification of poliovirus D-antigen
por: Dawson, Erica D., et al.
Publicado: (2022)

30-Minute Highly Multiplexed VaxArray Immunoassay for Pneumococcal Vaccine Antigen Characterization
por: Hu, Tianjing, et al.
Publicado: (2022)

VaxArray potency assay for rapid assessment of “pandemic” influenza vaccines
por: Byrne-Nash, Rose T., et al.
Publicado: (2018)

Preliminary multiplex microarray IgG immunoassay for the diagnosis of toxoplasmosis and rubella
por: Baschirotto, Priscila T, et al.
Publicado: (2017)

Two-dose measles–rubella vaccine schedule for measles–rubella elimination
por: John, T. Jacob
Publicado: (2023)

Influence of Sociodemographic Factors in Measles-Rubella Campaign Compared with Routine Immunization at Mysore City
por: Joe, Prathyusha, et al.
Publicado: (2019)

Difficulties in Eliminating Measles and Controlling Rubella and Mumps: A Cross-Sectional Study of a First Measles and Rubella Vaccination and a Second Measles, Mumps, and Rubella Vaccination
por: Wang, Zhifang, et al.
Publicado: (2014)

Measles and rubella microarray array patches to increase vaccination coverage and achieve measles and rubella elimination in Africa
por: Richardson, Lauren Christine, et al.
Publicado: (2020)

Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges
por: Hasso-Agopsowicz, Mateusz, et al.
Publicado: (2022)

Purulent Bronchitis Complicating Measles and Rubella
Publicado: (1919)

Genetic Characterization of Measles and Rubella Viruses Detected Through Global Measles and Rubella Elimination Surveillance, 2016–2018
por: Brown, Kevin E., et al.
Publicado: (2019)

Measles and rubella serosusceptibity among population vaccinated with different schedules: the potential impact on measles-rubella elimination in Iran
por: Saffar, Hana, et al.
Publicado: (2021)

Measles & rubella outbreaks in Maharashtra State, India
por: Vaidya, Sunil R., et al.
Publicado: (2016)

Rubella and Its Relations to Scarlet Fever and Measles
Publicado: (1908)

2017 Measles-Rubella Vaccination Campaign in India
por: Shrivastava, Saurabh RamBihariLal, et al.
Publicado: (2018)

Expansion of the measles and rubella laboratory network, India
por: Sharma, Deepa, et al.
Publicado: (2022)

Differential Diagnosis of Scarlet Fever, Measles and Rubella
Publicado: (1919)

Multiplexed, microscale, microarray-based serological assay for antibodies against all human-relevant coronaviruses
por: Dawson, Erica D., et al.
Publicado: (2021)

Modified measles versus rubella versus atypical measles: One and same thing
por: Gupta, Surender Nikhil, et al.
Publicado: (2015)

Use of a rapid digital microfluidics-powered immunoassay for assessing measles and rubella infection and immunity in outbreak settings in the Democratic Republic of the Congo
por: Knipes, Alaine K., et al.
Publicado: (2022)

The impact of Measles-Rubella vaccination on the morbidity and mortality from Congenital Rubella Syndrome in 92 countries
por: Vynnycky, Emilia, et al.
Publicado: (2018)

Mass Measles Rubella Immunization Campaign: Bhutan Experience
por: Giri, Bhakta R, et al.
Publicado: (2011)

Measles, Mumps, Rubella serology in juvenile idiopathic arthritis
por: Heijstek, MW, et al.
Publicado: (2008)

Characterizing the dynamics of rubella relative to measles: the role of stochasticity
por: Rozhnova, Ganna, et al.
Publicado: (2013)

Strengthening routine immunization through measles-rubella elimination
por: Biellik, Robin J., et al.
Publicado: (2018)

Measles-Rubella vaccination campaign: A trust deficit?
por: Sreedevi, A
Publicado: (2018)

Is it time to reconsider measles, mumps, and rubella immunisation strategies?
por: Boccalini, Sara, et al.
Publicado: (2021)

Measles-Mumps-Rubella Vaccine and COVID-19 Relationship
por: Özdemir, Öner
Publicado: (2020)

Towards elimination of measles and rubella in Italy: Progress and challenges
por: Adamo, Giovanna, et al.
Publicado: (2019)

Cost of conducting Measles-Rubella vaccination campaign in India
por: Chatterjee, Susmita, et al.
Publicado: (2021)

Immunogenicity of measles-rubella vaccine administered under India’s Universal Immunization Programme in the context of measles–rubella elimination goal: A longitudinal study
por: Verma, Santosh Kumar, et al.
Publicado: (2023)

1148. Long-term Persistence of Measles and Rubella Virus Neutralizing Antibody Levels among Adults with Three Doses of Measles-Mumps-Rubella Vaccine
por: Alonge, Oluwakemi, et al.
Publicado: (2023)

A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
por: Byrne-Nash, Rose T., et al.
Publicado: (2019)

2467. Timeliness of Childhood Vaccination With the Combination Measles–Mumps–Rubella–Varicella Vaccine vs. the Separate Measles–Mumps–Rubella and Varicella Vaccines in the United States
por: Wolfson, Lara, et al.
Publicado: (2018)

Early Onset Optic Neuritis Following Measles-Rubella Vaccination
por: Moradian, Siamak, et al.
Publicado: (2008)

Resurgence risk for measles, mumps and rubella in France in 2018 and 2020
por: Béraud, Guillaume, et al.
Publicado: (2018)

Utility of serological screening for measles, mumps and rubella in immunocompromised patients
por: Sticchi, L, et al.
Publicado: (2019)

Inadequate Measles, Mumps, Rubella, and Varicella Immunity Among Employees
por: Ezeji-Okoye, Stephen, et al.
Publicado: (2021)

Knowledge and Practice of Parents Towards Measles, Mumps and Rubella Vaccination
por: Hussein, Siti Zuhaida, et al.
Publicado: (2022)

Progress Toward Measles and Rubella Elimination — India, 2005–2021
por: Murugan, Ratnesh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aveebvvssh7nld06vkp61q7943